HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Paul Talalay Selected Research

sulforaphane

1/2019Sulforaphane enriched transcriptome of lung mitochondrial energy metabolism and provided pulmonary injury protection via Nrf2 in mice.
1/2017Sulforaphane from Broccoli Reduces Symptoms of Autism: A Follow-up Case Series from a Randomized Double-blind Study.
1/2017Correction: Lack of Effect of Oral Sulforaphane Administration on Nrf2 Expression in COPD: A Randomized, Double-Blind, Placebo Controlled Trial.
1/2016Lack of Effect of Oral Sulforaphane Administration on Nrf2 Expression in COPD: A Randomized, Double-Blind, Placebo Controlled Trial.
1/2016Biomarker-Guided Strategy for Treatment of Autism Spectrum Disorder (ASD).
6/2015Nrf2 Activation Protects against Solar-Simulated Ultraviolet Radiation in Mice and Humans.
10/2014Sulforaphane treatment of autism spectrum disorder (ASD).
9/2013Sulforaphane accelerates acetaldehyde metabolism by inducing aldehyde dehydrogenases: relevance to ethanol intolerance.
1/2013Keap1-nrf2 signaling: a target for cancer prevention by sulforaphane.
11/2012Neuroprotective effects of sulforaphane after contusive spinal cord injury.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Paul Talalay Research Topics

Disease

17Neoplasms (Cancer)
06/2015 - 02/2002
11Inflammation (Inflammations)
01/2016 - 08/2006
7Carcinogenesis
06/2015 - 01/2003
6Hepatocellular Carcinoma (Hepatoma)
09/2013 - 03/2005
5Chronic Disease (Chronic Diseases)
01/2017 - 08/2008
2Chronic Obstructive Pulmonary Disease (COPD)
01/2017 - 01/2016
2Autism Spectrum Disorder
01/2016 - 10/2014
2Mitochondrial Diseases (Mitochondrial Disease)
01/2016 - 11/2012
2Skin Neoplasms (Skin Cancer)
06/2015 - 04/2007
2Erythema
06/2015 - 10/2007
2Helicobacter Infections
05/2013 - 05/2002
2Infections
05/2013 - 10/2004
2Stomach Neoplasms (Stomach Cancer)
10/2004 - 05/2002
1Hyperoxia
01/2019
1Lung Injury
01/2019
1Autistic Disorder (Autism)
01/2017
1Neuroinflammatory Diseases
01/2016
1Hypoxia (Hypoxemia)
11/2013
1Breast Neoplasms (Breast Cancer)
11/2013
1Contusions
11/2012
1Spinal Cord Injuries (Spinal Cord Injury)
11/2012
1Weight Gain
08/2008
1Hypertension (High Blood Pressure)
06/2008
1Edema (Dropsy)
10/2007
1Epidermolysis Bullosa Simplex (Epidermolysis Bullosa Herpetiformis Dowling Meara)
09/2007
1Macular Degeneration (Age-Related Maculopathy)
07/2004

Drug/Important Bio-Agent (IBA)

18sulforaphaneIBA
01/2019 - 05/2002
10EnzymesIBA
05/2010 - 06/2004
4Oxidants (Oxidizing Agents)IBA
01/2019 - 10/2007
4PhytochemicalsIBA
01/2017 - 02/2012
4Biomarkers (Surrogate Marker)IBA
01/2016 - 10/2004
4CarcinogensIBA
06/2015 - 04/2007
4isothiocyanic acidIBA
02/2011 - 04/2007
4NAD (NADH)IBA
04/2008 - 06/2004
3AntioxidantsIBA
01/2016 - 07/2004
3AflatoxinsIBA
01/2013 - 11/2005
3Proteins (Proteins, Gene)FDA Link
10/2008 - 02/2004
3Reactive Oxygen Species (Oxygen Radicals)IBA
10/2008 - 02/2004
3quinone (benzoquinone)IBA
04/2008 - 03/2005
3Oxidoreductases (Dehydrogenase)IBA
04/2008 - 03/2005
2DNA (Deoxyribonucleic Acid)IBA
11/2013 - 04/2012
2butaneIBA
09/2013 - 05/2010
2GlucosinolatesIBA
09/2013 - 07/2007
2UreaseIBA
05/2013 - 10/2004
2CytokinesIBA
11/2012 - 07/2011
2glucoraphaninIBA
04/2010 - 07/2007
2IsothiocyanatesIBA
07/2007 - 02/2002
1GoldIBA
01/2016
1Free RadicalsIBA
11/2013
14-hydroxy-2-nonenal (4-hydroxynonenal)IBA
11/2013
1Estrogen ReceptorsIBA
11/2013
1tert-ButylhydroperoxideIBA
11/2013
1AmmoniaIBA
05/2013
1CalciumIBA
11/2012
1Glutathione (Reduced Glutathione)IBA
11/2012
1Glutamic Acid (Glutamate)FDA Link
11/2012
1Messenger RNA (mRNA)IBA
11/2012
1Neuroprotective AgentsIBA
11/2012
1Pharmaceutical PreparationsIBA
02/2012
1Environmental Pollutants (Pollutants, Environmental)IBA
01/2012
1Macrophage Migration-Inhibitory FactorsIBA
07/2011
1Nitric Oxide (Nitrogen Monoxide)FDA Link
05/2010
1Retinal Pigments (Pigments, Visual)IBA
05/2010
1LipopolysaccharidesIBA
05/2010
1Protective AgentsIBA
04/2010
1PowdersIBA
08/2008
1Retinaldehyde (Retinal)IBA
06/2008
1Biological ProductsIBA
06/2008
1Glutathione Transferase (Glutathione S-Transferase)IBA
04/2008
1LipidsIBA
10/2007
1Keratins (Keratin)IBA
09/2007
1Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA
07/2007
1Betulinic AcidIBA
07/2007
1thioglucosidaseIBA
07/2007
1TriterpenesIBA
07/2007
1anthraceneIBA
07/2007
1phenanthreneIBA
11/2005
1HydrocarbonsIBA
11/2005
1Sulfhydryl Compounds (Thiols)IBA
03/2005
1Urea (Carbamide)FDA LinkGeneric
10/2004
1NAD(P)H Dehydrogenase (Quinone) (Quinone Reductase)IBA
06/2004
1XenobioticsIBA
06/2004
1Mitochondrial DNA (mtDNA)IBA
02/2003
1Oxygen (Dioxygen)IBA
01/2003
1Anti-Bacterial Agents (Antibiotics)IBA
05/2002
1Benzo(a)pyreneIBA
05/2002
1InsecticidesIBA
02/2002

Therapy/Procedure

1Therapeutics
01/2017
1Plant-Based Diet
04/2012
1Caloric Restriction
08/2008
1Oral Administration
07/2007